Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MP-376 for Prevention of Acute Exacerbations in COPD
NCT00739648Phase 2Completed
- Sponsor
- Amgen
- Start
- Oct 2008
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of levofloxacin inhalation solution in chronic obstructive pulmonary disease (COPD), sponsored by Amgen. Started Oct 2008; status: completed.
02
Drugs
levofloxacin inhalation solution
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00739648.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00739648.